Skip to content

Study · Not a test of the peptide alone · 2005

1 result

A rapid and sensitive assay for quantification of siRNA efficiency and specificity.

Smart N, Scambler PJ, Riley PR

Biological procedures online24 Jan 2005Cited by 20 (Europe PMC)

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study1

No result from this study comes from a test of the peptide.

Studies that did not test the peptide alone1

In this study, Thymosin beta-4 (human) was a lab tool or a carrier, part of a mix, or the subject of a lab method. These results are not evidence about taking Thymosin beta-4 (human).

  1. 01LabNot a test of Thymosin beta-4 (human) aloneIn vitro (cells)Other

    In a luciferase reporter assay, siRNAs directed against Tbeta4 silenced Tbeta4, did not silence the homologue Tbeta10 off target, and partly knocked down Tbeta10 despite sequence mismatch.

    In plain wordsIn lab tests, a reporter assay measured how well siRNAs silence the Tbeta4 gene and whether they also hit a related gene.

    Outcome
    Not applicablesiRNA efficacy and specificity against Tbeta4 and Tbeta10
    Study

    n: not reported in source

    luciferase reporter assay
    Outcome group
    Receptor activity and mechanism · Pharmacology

    Source sentences

    Summary
    We have tested different siRNAs directed against Thymosin beta4 (Tbeta4); determined their effectiveness at silencing Tbeta4 and have both excluded off-target silencing of the Tbeta4 homologue Thymosin beta10 (Tbeta10) and demonstrated partial knockdown of Tbeta10 despite significant (12/23; 52%) sequence mismatch.
    1 context sentence
    Summary · context
    To this end, we have adapted a reporter-based assay harnessing the sensitivity of luciferase activity to provide a quantitative readout of relative RNAi efficacy and specificity.

    In this study, Thymosin beta-4 (human) was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking Thymosin beta-4 (human).

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 2Current

    13 Oct 2026, 01:52 UTC

    Study results updated

  2. Version 1

    12 Oct 2026, 18:17 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

PepBank is a research reference. Talk to a doctor before you use any peptide.